Clinical Trials Directory

Trials / Terminated

TerminatedNCT03471013

Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia

Status
Terminated
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Only one third of patients with schizophrenia are observant to their treatment knowing that the lack of adherence to treatment is one of the most important predictors of relapse. Recent work shows that the erroneous or negative beliefs of patients with schizophrenia regarding antipsychotic treatment are associated with poor compliance. The hypothesis is that negative beliefs about the antipsychotic treatment of caregivers of patients with schizophrenia may be associated with a higher risk of poor compliance compared to caregivers with positive beliefs about treatment. The primary purpose is to explore the correlation between caregiver beliefs about treatment and patient compliance, taking into account the level of caregiver-patient link.

Detailed description

Non-interventional cross-sectional exploratory study with a single visit for patients with schizophrenia and their caregivers, who agreed to participate in the protocol.

Conditions

Timeline

Start date
2018-03-20
Primary completion
2025-07-10
Completion
2026-02-02
First posted
2018-03-20
Last updated
2026-02-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03471013. Inclusion in this directory is not an endorsement.

Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia (NCT03471013) · Clinical Trials Directory